New medical treatment strategies for nonalcoholic steatohepatitis

Current Treatment Options in Gastroenterology
Michael Fuchs

Abstract

Nonalcoholic steatohepatitis (NASH) is a severe form of fatty liver disease unrelated to chronic alcohol consumption. As nonalcoholic fatty liver disease (NAFLD) has reached epidemic proportions and is becoming the most common cause for chronic liver disease, NASH likely will replace chronic hepatitis C as leading indication for liver cirrhosis and liver transplantation in this decade. Despite this alarming trend, effective treatment is lacking and continues to rely on dietary interventions and physical exercise, known to be of limited effect. Hence, there is an urgent need for safe pharmacologic therapy that successfully reverses or prevents progression of liver injury and fibrosis in patients with NASH. Employing emerging concepts of disease development and progression that involve in parallel ongoing events originating from the liver, adipose tissue, and intestine will ultimately promote the development of effective agents for targeted therapies for NASH. Novel agents must be safe, optimally dosed, and finally pass clinical trials providing proof of concept and efficacy. In the case of NASH, trial design is not necessarily straightforward as surrogate end points to predict clinical benefits are not yet established. The level...Continue Reading

References

Oct 3, 2001·Journal of Hepatology·M Parola, G Robino
Nov 13, 2004·Annals of Internal Medicine·Edgar R MillerEliseo Guallar
Feb 14, 2006·Proceedings of the National Academy of Sciences of the United States of America·Takeshi InagakiSteven A Kliewer
Apr 19, 2006·Journal of Hepatology·John Willy HaukelandPål Aukrust
May 4, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Kanji YamaguchiAnna Mae Diehl
May 15, 2007·Gastroenterology·Laurie L Baggio, Daniel J Drucker
Jun 5, 2007·Clinics in Liver Disease·Janus P Ong, Zobair M Younossi
Feb 12, 2008·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·C Fernández-MirandaJ A Solís-Herruzo
May 8, 2008·Current Opinion in Lipidology·Steve S Choi, Anna Mae Diehl
Aug 2, 2008·Nature Reviews. Drug Discovery·Charles ThomasKristina Schoonjans
Oct 24, 2008·Alimentary Pharmacology & Therapeutics·R LoombaJ H Hoofnagle
Oct 29, 2008·Seminars in Liver Disease·Mariana Lazo, Jeanne M Clark
Nov 8, 2008·European Journal of Gastroenterology & Hepatology·Daniel R GayaAdrian J Stanley
Nov 26, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Onpan CheungArun J Sanyal
Mar 18, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Luca MieleAntonio Grieco
Aug 14, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Rafal P WitekAnna Mae Diehl
Sep 3, 2009·Cell Metabolism·Charles ThomasKristina Schoonjans
Dec 17, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Cecilia SöderbergRolf Hultcrantz
Apr 30, 2010·The New England Journal of Medicine·Arun J SanyalUNKNOWN NASH CRN
May 11, 2010·Gastroenterology·Jody DushayEleftheria Maratos-Flier
Oct 26, 2010·Antioxidants & Redox Signaling·Roberto GambinoMaurizio Cassader
Nov 6, 2010·BMJ : British Medical Journal·Markus SchürksTobias Kurth
Mar 31, 2011·European Journal of Gastroenterology & Hepatology·Srinivasan DasarathySatish C Kalhan
Apr 12, 2011·Expert Review of Gastroenterology & Hepatology·Muhammad Amir, Mark J Czaja
Jun 30, 2011·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Arun J Sanyal
Aug 2, 2011·Journal of Hepatology·Lien F R ThoenLeo A van Grunsven
Aug 23, 2011·Journal of Hepatology·Christine C Hsu, Robert F Schwabe
Sep 9, 2011·Digestive Diseases and Sciences·Michele MalaguarneraFabio Galvano
Oct 13, 2011·JAMA : the Journal of the American Medical Association·Eric A KleinLaurence H Baker
Oct 14, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Diana JokaHeike Bantel
Oct 19, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Vlad RatziuMario Chojkier
Mar 23, 2012·Nature Reviews. Molecular Cell Biology·Veerle Rottiers, Anders M Näär
May 9, 2012·Cell Metabolism·Christopher K Glass, Jerrold M Olefsky
May 24, 2012·Free Radical Biology & Medicine·Joy X JiangNatalie J Török
Jul 19, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Tomonori AoyamaDavid A Brenner
Jul 24, 2012·The Journal of Clinical Investigation·Shu-Hao HsuKalpana Ghoshal

❮ Previous
Next ❯

Citations

Jun 16, 2021·Journal of Gastroenterology and Hepatology·Susrichit PhrueksotsaiSatawat Thongsawat

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nihon rinsho. Japanese journal of clinical medicine
Keisuke OeToshiji Saibara
JAMA : the Journal of the American Medical Association
Joel E LavineNonalcoholic Steatohepatitis Clinical Research Network
Clinics in Liver Disease
Vlad Ratziu, Shira Zelber-Sagi
Romanian Journal of Internal Medicine = Revue Roumaine De Médecine Interne
Carmen Fierbinteanu-BraticeviciR Usvat
© 2021 Meta ULC. All rights reserved